SCHEMBL23296338

SCHEMBL23296338

Cc1cc(-c2cc(-n3c4ccccc4c4cnccc43)c(C#N)c(-n3c4ccccc4c4cnccc43)c2)cc(C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.42
MAOA P21397 5/20 0.39
MAOB P27338 4/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
ACHE P22303 1/20 0.39
TOP2A P11388 1/20 0.38
PDE10A Q9Y233 1/20 0.37
CYP2D6 P10635 1/20 0.37
CLK1 P49759 1/20 0.35
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
CDK5 Q00535 1/20 0.35
DYRK1A Q13627 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23296326 0.93 CYP11B2 (0.42) CYP11B2MAOANCOA3TOP2APDE10A
SCHEMBL19909065 0.90 ALDH1A1 (0.40) CYP11B2HPGDMAPK1SMN1; SMN2KDM4E
SCHEMBL31272671 0.88 CYP11B2 (0.42) CYP11B2MAOAMAOBNCOA3ACHE
SCHEMBL23296373 0.86 CYP11B2 (0.38) CYP11B2MAOAMAOBNCOA3ACHE
SCHEMBL23296364 0.84 SQOR (0.42) CYP11B2MAOAMAOBNCOA3ACHE
SCHEMBL31272453 0.84 SQOR (0.42) CYP11B2MAOAMAOBNCOA3ACHE
SCHEMBL23296330 0.84 CYP11B2 (0.42) CYP11B2MAOAMAOBNCOA3ACHE
SCHEMBL19909184 0.83 ALDH1A1 (0.36) CYP11B2HPGDMAPK1SMN1; SMN2KDM4E
SCHEMBL19913305 0.83 ALDH1A1 (0.36) CYP11B2HPGDMAPK1SMN1; SMN2KDM4E
SCHEMBL19909132 0.83 PDE9A (0.37) CYP11B2NCOA3HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885MAOA 123/4885MAOB 95/4885
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885MAOA 123/4885MAOB 95/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885MAOA 123/4885MAOB 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.